Sample to Outcome

WIPO WIPO 2019

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke Sample to Outcome wurde als Wortmarke am 21.05.2019 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 01. Januar 2021

Markenform Wortmarke
Aktenzeichen 1481072
Länder Schweiz China Großbritannien Japan Vereinigte Staaten von Amerika (USA)
Basismarke EU Nr. 017995094, 30. November 2018
Anmeldedatum 21. Mai 2019
Ablaufdatum 21. Mai 2029

Markeninhaber

Qiagen Str. 1
40724 Hilden
DE

Markenvertreter

Waren und Dienstleistungen

09 Computer software; computer software and related databases for use in nucleic acid and protein assay analysis and for quality control, validation, interpretation, reporting, clinical decision support, data management, integration with medical records, physician portals, laboratory networking, professional healthcare and trial matching services all related to molecular and genomic analysis; computer software, namely evidence-based decision support software used as an aid in the interpretation of variants observed in genomic sequencing data; computer software for evaluation of genomic variants in the context of published biomedical literature, professional association guidelines, publicly available databases and annotations, drug labels, and/or clinical-trials; computer software for bioinformatics analyses, optionally combined with data management, graphical viewing and output options; computer programs and software for biological data mining; computer programs and software for developing bioinformatics database for others; bio-chips for research or scientific purposes; DNA-chips; RNA-chips; next-generation sequencing (ngs) data processor; bioinformatics data processor; online non-downloadable software for use in bioinformatics, genomics, phenomics, microbiome, and metagenomics applications; computer hardware and software for collecting, storing, analyzing, visualizing, and interpreting bioinformatics, genomics, and phenomics data sets; computer hardware and software for the monitoring of pathogens; computer hardware and software for receiving, processing, transmitting and displaying associated genomics and phenomics data; computer databases for bioinformatics, genomics, phenomics, microbiome, metagenomics, organism-and -pathogen-specific genotype records, and organism and pathogen-specific phenotype information; computer software for use in the integration, analysis and visualization of biomedically relevant information allowing users to explore compound, target, assay, biological pathway and disease information; computer software and databases for the analysis of genomes, exomes, targeted amplicons, transcriptomes, and epigenetic NGS sequencing data; computer software, tools, and visualization modules, for analysis, discovery, verification, and validation of disease biomarkers
10 Medical diagnostic testing instruments for processing and analysis of genetic samples primarily for single-cell genomic, transcriptomic, or proteomic analysis; medical and diagnostic apparatus for tests, using gene expression tests, gene expression profiling assays, genetic information and data, protein biomarkers, clinical data, and/or demographic information; testing apparatus for medical purposes with respective use of bioinformatics and machine learning algorithms and medical data to support treatment decisions; medical test apparatus quantifying biomarker levels and relative expression of host response genes; medical apparatus and instruments for detecting tumor cancer, heredity and genetic diseases; testing apparatus for samples of body fluids, tissue and organ; genome machine for medical purposes; diagnostic apparatus for the detection of cancer, genetic or heredity diseases
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
24. Oktober 2020 2020/52 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
10. September 2020 2020/38 Gaz JP Ablehnung
03. Juli 2020 2020/28 Gaz CH Ablehnung
10. Dezember 2019 2019/50 Gaz GB Ablehnung
08. Oktober 2019 2019/41 Gaz CN Ablehnung
04. September 2019 2019/36 Gaz US Ablehnung
16. August 2019 2019/34 Gaz GB Ablehnung
21. Mai 2019 2019/30 Gaz EM Eintragung

ID: 141481072